EFFECT OF FOOD ON PHARMACOKINETICS AND SAFETY OF DA-8010, A NOVEL SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS

被引：0
|
作者：
Khwarg, J. [1 ]
Yang, E. [1 ]
Chung, W. [1 ]
Park, S. [1 ]
Jang, I [1 ]
Cho, J. [1 ]
Ryu, C. [2 ]
Lee, D. [2 ]
Lee, M. [2 ]
Kim, H. [3 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea
[2] Dong A ST Res Inst, Yongin, South Korea
[3] Dong A ST Co Ltd, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 78卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
31
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [31] A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects
    Wang, Fei
    He, Jingjing
    Zhou, Yanling
    Ye, Lijun
    Li, Bei
    Ma, Zhiyuan
    Chen, Chunyan
    Zhang, Ruoxi
    Lin, Zhaocun
    Tang, Jinshan
    Jin, Zhiping
    Jiang, Yu
    Lin, Nengming
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [32] Effect of Food on the Single-Dose Pharmacokinetics and Safety of Ulipristal Acetate in Healthy Chinese Subjects
    Wang, Yilin
    Li, Yanru
    Peng, Chun
    Tang, Ling
    Wang, Yan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (03): : 542 - 545
  • [33] Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
    Wang, Shining
    Chen, Grace
    Merlo Pich, Emilio
    Affinito, John
    Cwik, Michael
    Faessel, Helene
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4354 - 4365
  • [34] Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects
    Yin, Wei
    Mamashli, Fahimeh
    Buhl, Derek L.
    Khudyakov, Polyna
    Volfson, Dmitri
    Martenyi, Ferenc
    Gevorkyan, Hakop
    Rosen, Laura
    Simen, Arthur A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (02) : 600 - 612
  • [35] An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects
    Round, Patrick
    Priestley, Anthony
    Robinson, Jan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (06) : 921 - 931
  • [36] Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist
    Brown, William
    Leff, Richard L.
    Griffin, Andrew
    Hossack, Stuart
    Aubray, Roxane
    Walker, Philippe
    Chiche, Dan A.
    JOURNAL OF PAIN, 2017, 18 (06): : 726 - 738
  • [37] Pharmacokinetics and short-term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects
    Adkison, KK
    Shachoy-Clark, A
    Fang, L
    Lou, Y
    O'Mara, K
    Berrey, MM
    Piscitelli, SC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2802 - 2806
  • [38] Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects
    Ghim, Jong-Lyul
    Paik, Soo Heui
    Hasanuzzaman, M.
    Chi, Yong Ha
    Choi, Hyang-Ki
    Kim, Dong-Hyun
    Shin, Jae-Gook
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (05): : 576 - 580
  • [39] Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects
    Weber, C
    Schmitt, R
    Birnboeck, H
    Hopfgartner, G
    vanMarle, SP
    Peeters, PAM
    Jonkman, JHG
    Jones, CR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (02) : 124 - 137
  • [40] Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects
    Namour, Florence
    Galien, Rene
    Van Kaem, Tim
    Van der Aa, Annegret
    Vanhoutte, Frederic
    Beetens, Johan
    Van't Klooster, Gerben
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (01) : 139 - 148
12345